Viewing Study NCT02977312


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-03-01 @ 12:16 AM
Study NCT ID: NCT02977312
Status: COMPLETED
Last Update Posted: 2016-11-30
First Post: 2016-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of CemivilĀ® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
Sponsor: Hikma Pharmaceuticals LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module